Caribou Biosciences (CRBU) Change in Receivables (2020 - 2026)
Caribou Biosciences' (CRBU) quarterly Change in Receivables came in at $158000.0 in Q1 2026, up 189.27% year-on-year from $54621.1 in Q1 2025, and up 191.33% on a QoQ basis from -$173000.0 in Q4 2025.
Caribou Biosciences (CRBU) Change in Receivables (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of Change in Receivables data on file, last reported at $158000.0 in Q1 2026.
- On a quarterly basis, Change in Receivables rose 189.27% year-over-year to $158000.0 in Q1 2026; TTM through Mar 2026 was $139000.0, a 116.75% increase from a year earlier, with the FY2025 full-year figure at -$196000.0, down 267.52% from the prior year.
- Change in Receivables for Q1 2026 stood at $158000.0, up from -$173000.0 in the prior quarter.
- Over the last five years, Change in Receivables for CRBU reached as high as $1.3 million in Q1 2023 and fell as low as -$985000.0 in Q4 2023.
- Historically, Change in Receivables has averaged -$54470.6 across 5 years, with a median of -$32000.0 in 2024.
- Across the five-year window, Change in Receivables tumbled 952.7% in 2022 and surged 634.38% in 2025, its largest moves.
- Year by year, Change in Receivables stood at -$195000.0 in 2022, then slumped by 405.13% to -$985000.0 in 2023, then soared by 108.22% to $81000.0 in 2024, then plunged by 313.58% to -$173000.0 in 2025, then soared by 191.33% to $158000.0 in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $158000.0 in Q1 2026, -$173000.0 in Q4 2025, and $171000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - | 158,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 158,000.00 |
| Mar 31, 2026 | 158,000.00 |
| Dec 31, 2025 | -173,000.00 |
| Dec 31, 2025 | -173,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Jun 30, 2025 | -17,000.00 |
| Jun 30, 2025 | -17,000.00 |
| Mar 31, 2025 | -177,000.00 |
| Mar 31, 2025 | -177,000.00 |
| Dec 31, 2024 | 81,000.00 |
| Dec 31, 2024 | 81,000.00 |
| Sep 30, 2024 | -32,000.00 |
| Sep 30, 2024 | -32,000.00 |
| Jun 30, 2024 | -702,000.00 |
| Jun 30, 2024 | -702,000.00 |
| Mar 31, 2024 | 770,000.00 |
| Mar 31, 2024 | 770,000.00 |
| Dec 31, 2023 | -985,000.00 |
| Dec 31, 2023 | -985,000.00 |